A substantial advancement in glucose management is emerging with the approval of tirzepatide at a dosage of 45mg. This updated version builds upon the existing success of tirzepatide, a dual GIP and GLP-1 target, and https://emilianoeg357725.fireblogz.com/72379742/revolutionary-development-tirzepatide-45mg-for-glucose-regulation